Hanauer Landstraße 146
D-60314 Frankfurt am Main
Telefon: +49 69 24 75 61 72
Company Listing: Frankfurt am Main HRB 92 462
USt-IdNr.: DE 281 453 101
Managing Directors: Dr. Giuseppe Gianni, Prof. Dr. Thomas Bauknecht
Management and medical-scientific conception
Dr. rer nat. Giuseppe Gianni
Prof. Dr. med. Thomas Bauknecht,
PD. Dr. med. Jan Gärtner
Conception / design
Anja Amankona, Brand Health GmbH
Dr. Giuseppe Gianni, Brand Health GmbH
Data protection officer
Ovidiu Karagena, appPeople GmbH
FDA (Food and Drug Administration) UDoHaHS, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), Center for Devices and Radiological Health (CDRH). Guidance for Industry: Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims [online]. December 2009 [Zugriff: 18.02.2014]. URL: http://www.fda.gov/downloads/Drugs/Guidances/UCM193282.pdf.
Gaertner J, Weingärtner V, Wolf J, Voltz R. Early palliative care for patients with advanced cancer: how to make it work? Curr Opin Oncol. 2013 Jul; 25 (4):342-52.
Gaertner J, Becker G. Patients with advanced disease: the value of patient reported outcomes. Oncol Res Treat. 2014; 37 (1-2):7-8.
Glare PA, Davies PS, Finlay E, Gulati A, Lemanne D, Moryl N, Oeffinger KC, Paice JA, Stubblefield MD, Syrjala KL. Pain in Cancer Survivors. J Clin Oncol. 2014 May 5. [Epub ahead of print]
Holland JC, Andersen B, Breitbart WS, Buchmann LO, Compas B, Deshields TL et al. Distress management. J Natl Compr Canc Netw. 2013 Feb 1; 11 (2):190-209.
Muehlhausen W, Doll H, Quadri N, Fordham B, O'Donohoe P, Dogar N, Wild DJ. Equivalence of electronic and paper administration of patient-reported outcome measures: a systematic review and meta-analysis of studies conducted between 2007 and 2013. Health Qual Life Outcomes. 2015 Oct 7; 13 (1):167.
Stinson JN, Jibb LA, Nguyen C, Nathan PC, Maloney AM, Dupuis LL, Gerstle JT, Hopyan S, Alman BA, Strahlendorf C, Portwine C, Johnston DL.
Construct validity and reliability of a real-time multidimensional smartphone app to assess pain in children and adolescents with cancer.
Pain. 2015 Dec;156(12):2607-2615
Smith TG, Castro KM, Troeschel AN, Arora NK, Lipscomb J Jones SM, Treiman KA, Hobbs C, McCabe RM, Clauser SB
The rationale for patient-reported outcomes surveillance in cancer and a reproducible method for achieving it.
Cancer. 2015 Nov 30. [Epub ahead of print]
Quinten C, Coens C, Mauer M, Comte S, Sprangers MA, Cleeland C, Osoba D, Bjordal K. Bottomley A Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials. Lancet Oncol. 2009 Sep; 10 (9):865-71.
No personal and location-specific data is collected within the app and forwarded to external servers.
The app has been developed in cooperation with scientific experts and based on proven methods. It has been extensively tested and is continuously being further developed. Nevertheless, the operator of the service assumes no legal responsibility for the correctness of the calculations, data and information presented.
By using the MeQol® App ( "the App"), you waive any and all claims, claims and claims against app-People GmbH (including its employees), which in any way affect the use of the app and the information / Data. You also agree that the app's data is used solely for the personal logging of your pain and quality of life.
The data collected with the app must not be used for diagnosis or treatment. The use of the MeQol® App does not replace a personal interview with a doctor or other medical professional. All information and illustrations contained in the app are the intellectual property of appPeople GmbH and may not be reproduced without written consent.